Efficacy and Safety of Crizotinib among Chinese EML4-ALK-Positive, Advanced-Stage Non-Small Cell Lung Cancer Patients

• Yabing Cao ,

  * E-mail: sumscaoyabing@hotmail.com

  Affiliation Department of Oncology, Kiang Wu Hospital, Estrada do Repouso, Macau, China, 999999

  ⨯
• Guangli Xiao,

  Affiliation Department of Oncology, Kiang Wu Hospital, Estrada do Repouso, Macau, China, 999999

  ⨯
• Xibin Qiu,

  Affiliation Department of Oncology, Kiang Wu Hospital, Estrada do Repouso, Macau, China, 999999

  ⨯
• Sheng Ye,

  Affiliation Department of Oncology, The First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan 2nd Road, Guangzhou, Guangdong, P.R. China, 510080

  ⨯
• Tongyu Lin

  Affiliation Cancer Center of Sun Yat-sen University, State Key Laboratory of Oncology in Southern China, Department of Medical Oncology, No. 651 Dongfeng Road East, Guangzhou, Guangdong, P.R. China, 510060

  ⨯